VIVUS Announces Date of First Quarter 2013 Financial Results and Conference Call

VIVUS Announces Date of First Quarter 2013 Financial Results and Conference

MOUNTAIN VIEW, Calif., May 1, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc.
(Nasdaq:VVUS) today announced that it will report financial results for the
first quarter ended March 31, 2013 before the NASDAQ Market opens on
Wednesday, May 8, 2013. The company will conduct a conference call and an
audio webcast at 8:30am EDT the same day.

Date:  May 8, 2013

Time: 8:30 AM EDT

Listen via Internet:

U.S. Toll-free: 877-359-2916

Outside U.S.:(+) 224-357-2386

A webcast replay will be available on the VIVUS website for 30 days.


VIVUS is a biopharmaceutical company commercializing and developing
innovative, next-generation therapies to address unmet needs in obesity, sleep
apnea, diabetes and sexual health. For more information about the company,
please visit

Certain statements in this press release are forward-looking within the
meaning of the Private Securities Litigation Reform Act of 1995. These
statements may be identified by the use of forward-looking words such as
"anticipate," "believe," "estimate," "expect", "forecast," "intend," "likely,"
"may," "plan," "potential," "predict," "opportunity" and "should," among
others. There are a number of factors that could cause actual events to differ
materially from those indicated by such forward-looking statements. VIVUS does
not undertake an obligation to update or revise any forward-looking
statements. Investors should read the risk factors set forth in VIVUS' Form
10-K for the year ending December 31, 2012, and periodic reports filed with
the Securities and Exchange Commission.

         Timothy E. Morris
         Chief Financial Officer
         Dana B. Shinbaum
         Investor Relations:
         The Trout Group
         Brian Korb
         Morrow & Co., LLC
         Joseph J. Mills
         Media Relations:
         Ashley Buford
         (212) 373-6045
         Joele Frank, Wilkinson Brimmer Katcher
         Matthew Sherman | Jennifer Beugelmans |
         212-235-2665 | 212-895-8692
Press spacebar to pause and continue. Press esc to stop.